Literature DB >> 10588018

An epizootic of Rift Valley fever in Egypt in 1997.

I H Abd el-Rahim1, U Abd el-Hakim, M Hussein.   

Abstract

An epizootic of Rift Valley fever (RVF) occurred in Egypt between April and August 1997. The signs among infected cattle and sheep were high fever, icterus, bloody diarrhoea and abortion. Aborted sheep foetuses and sera from the affected herds were collected in the Aswan and Assiut Provinces, Upper Egypt, for virological and serological examination. A cytopathic effect was detected in Vero cell cultures 48 h after inoculation with the foetal liver and spleen suspensions. The same suspensions caused paralysis and mortalities two to three days post intracerebral injection in mice. The isolated virus was identified using an agar gel precipitation test (AGPT) and a direct fluorescent antibody technique. Serological examination revealed that all tested sheep (57) and cattle (93) gave positive results to serological tests, using a complement fixation (CF), serum neutralisation (SN) and indirect immunofluorescence assay; while only 48 (84.2%) out of 57 sheep sera and 69 (74.2%) out of 93 cattle sera gave positive results using an AGPT. Titration of the serum samples indicated that SN is more sensitive than CF. Importation of infected ruminants, especially camels from the Sudan, is the principal source of infection. Aswan, the nearest Egyptian province to the Sudan, is the focus of RVF virus infection in Egypt. As a result of high insect populations, the epizootics of RVF have usually occurred during the summer in Egypt. Reoccurrence of epizootics from time to time indicates failure of the applied RVF vaccination programme in Egypt.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588018     DOI: 10.20506/rst.18.3.1195

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  32 in total

1.  Risk assessment of the introduction of Rift Valley fever from the Horn of Africa to Yemen via legal trade of small ruminants.

Authors:  Shaif Abdo-Salem; Agnès Waret-Szkuta; François Roger; Marie-Marie Olive; Khalid Saeed; Véronique Chevalier
Journal:  Trop Anim Health Prod       Date:  2010-10-22       Impact factor: 1.559

2.  A model for the coupling of the Greater Bairam and local environmental factors in promoting Rift-Valley Fever epizootics in Egypt.

Authors:  H Gil; W A Qualls; C Cosner; D L DeAngelis; A Hassan; A M Gad; S Ruan; S R Cantrell; J C Beier
Journal:  Public Health       Date:  2015-08-19       Impact factor: 2.427

3.  Simultaneous detection of Rift Valley Fever, bluetongue, rinderpest, and Peste des petits ruminants viruses by a single-tube multiplex reverse transcriptase-PCR assay using a dual-priming oligonucleotide system.

Authors:  Jung-Yong Yeh; Ji-Hye Lee; Hyun-Ji Seo; Jee-Yong Park; Jin-San Moon; In-Soo Cho; In-Soo Choi; Seung-Yong Park; Chang-Seon Song; Joong-Bok Lee
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

4.  A statistical model of Rift Valley fever activity in Egypt.

Authors:  John M Drake; Ali N Hassan; John C Beier
Journal:  J Vector Ecol       Date:  2013-12       Impact factor: 1.671

5.  Rift Valley fever virus seroprevalence in human rural populations of Gabon.

Authors:  Xavier Pourrut; Dieudonné Nkoghé; Marc Souris; Christophe Paupy; Janusz Paweska; Cindy Padilla; Ghislain Moussavou; Eric M Leroy
Journal:  PLoS Negl Trop Dis       Date:  2010-07-27

Review 6.  Global change and human vulnerability to vector-borne diseases.

Authors:  Robert W Sutherst
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

7.  Modeling the spatial spread of Rift Valley fever in Egypt.

Authors:  Daozhou Gao; Chris Cosner; Robert Stephen Cantrell; John C Beier; Shigui Ruan
Journal:  Bull Math Biol       Date:  2013-02-02       Impact factor: 1.758

8.  Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene.

Authors:  Anna Maria Copeland; Louis A Altamura; Nicole M Van Deusen; Connie S Schmaljohn
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

Review 9.  Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

Authors:  Michele Bouloy; Ramon Flick
Journal:  Antiviral Res       Date:  2009-08-12       Impact factor: 5.970

Review 10.  Crimean-Congo hemorrhagic fever and expansion from endemic regions.

Authors:  Jessica R Spengler; Éric Bergeron; Christina F Spiropoulou
Journal:  Curr Opin Virol       Date:  2019-01-16       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.